Patient Safety

Medsafe has decided to ban pholcodine-containing cough syrups and lozenges but will not be recalling them 

The Environmental Protection Agency is considering banning cosmetics that contain PFAS chemicals

New studies are confirming earlier findings that the side effects of statins are largely “fake news”, says cardiologist Gerard Wilkins

A Medsafe committee says pholcodine-based dry cough syrups and lozenges, including some Difflam, Duro-Tuss and Pholcodine Linctus products, should be banned 

Auckland University researchers want to hear pharmacists’ experiences and opinions on the rescheduling of codeine and its impacts on patients

Legally the supply period for class B opioid prescriptions has now reverted back to a maximum period of one month, instead of three months

Warning over men’s use of Epilim at time of conception issued by Medsafe 

Australia and Europe have banned medicines containing pholcodine. Now Medsafe is considering whether New Zealand should follow suit

Many pharmacists fear making controlled drugs more available would lead criminals to increasingly target pharmacies at the same time as it potentially worsened opioid addiction problems

Neomai Moa Akauola had been on blood-thinning medication for years – but her GP clinic wasn’t testing the ability of her blood to clot